References
- Pliaka V, Kyriakopoulou Z, Markoulatos P. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Expert Rev. Vaccines 11(5), 609–628 (2012).
- Joce R, Wood D, Brown D, Begg N. Paralytic poliomyelitis in England and Wales, 1985–91. BMJ 305(6845), 79–82 (1992).
- Yu J, Chou AJ, Lennox A et al. Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients. Pediatr. Blood Cancer 49(5), 656–660 (2007).